Ginkgo Bioworks sells Biosecurity segment to Tower Biosecurity for 20% stake

Ginkgo Bioworks Holdings, Inc.

Ginkgo contributes all equity of Ginkgo Biosecurity, LLC (its Biosecurity segment) to Tower Biosecurity.
In exchange, Ginkgo receives shares representing ~20% of Tower Biosecurity on a fully diluted basis.
Transaction expected to close in first half of 2026, subject to customary closing conditions.
Seller is Ginkgo Bioworks, Inc.; parent Ginkgo Bioworks Holdings is party for limited purposes.
No cash purchase price disclosed; consideration is solely an equity stake in the acquirer.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.